SHANGHAI, Dec. 4, 2025 /PRNewswire/ -- OTR Therapeutics, a biotechnology company dedicated to transforming early-stage innovations into globally impactful therapies, emerged from stealth and announced today the successful completion of a $100 million Series A financing closed in June 2025....
Hence then, the article about otr therapeutics raises 100 million in series a financing to advance early innovation into global transformative therapies was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( OTR Therapeutics Raises $100 Million in Series A Financing to Advance Early Innovation into Global Transformative Therapies )
Also on site :
- ‘Modern Family’ Star Reveals Why He Changed His Mind About Filming a Spinoff
- Dunkin’s At Home Line Expands With New Espresso Options
- Trump’s loss of $1.7 trillion in tariff revenue will send the national debt to $58 trillion by 2036, think tank projects